Comparative characterization of PCDH19 missense and truncating variants in PCDH19-related epilepsy
Missense and truncating variants in protocadherin 19 ( PCDH19 ) cause PCDH19 -related epilepsy. In this study, we aimed to investigate variations in distributional characteristics and the clinical implications of variant type in PCDH19 -related epilepsy. We comprehensively collected PCDH19 missense...
Gespeichert in:
Veröffentlicht in: | Journal of human genetics 2021-06, Vol.66 (6), p.569-578 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Missense and truncating variants in protocadherin 19 (
PCDH19
) cause
PCDH19
-related epilepsy. In this study, we aimed to investigate variations in distributional characteristics and the clinical implications of variant type in
PCDH19
-related epilepsy. We comprehensively collected
PCDH19
missense and truncating variants from the literature and by sequencing six exons and intron–exon boundaries of
PCDH19
in our cohort. We investigated the distribution of each type of variant using the cumulative distribution function and tested for associations between variant types and phenotypes. The distribution of missense variants in patients was clearly different from that of healthy individuals and was uniform throughout the extracellular cadherin (EC) domain, which consisted of six highly conserved domains. Truncating variants showed two types of distributions: (1) located from EC domain 1 to EC domain 4, and (2) located from EC domain 5 to the cytoplasmic domain. Furthermore, we also found that later onset seizures and milder intellectual disability occurred in patients with truncating variants located from EC domain 5 to the cytoplasmic domain compared with those of patients with other variants. Our findings provide the first evidence of two types of truncating variants in the
PCDH19
gene with regard to distribution and the resulting clinical phenotype. |
---|---|
ISSN: | 1434-5161 1435-232X |
DOI: | 10.1038/s10038-020-00880-z |